DOCU Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
DocuSign Inc is not a strong buy for a beginner, long-term investor at this time. While the company has shown some financial growth in its latest quarter and has positive news regarding its partnership with Anthropic's AI platform, the overall sentiment from analysts, insider and hedge fund trading trends, and technical indicators suggest caution. The stock faces challenges from AI disruption in the software sector, and recent downgrades by analysts indicate limited growth visibility. The lack of strong proprietary trading signals further supports a hold recommendation.
The MACD is positive and expanding, indicating bullish momentum. RSI is neutral at 69.763, and moving averages are converging, showing no clear trend. The stock is trading near resistance levels (R1: 47.837, R2: 49.832), suggesting limited immediate upside potential.
DocuSign's partnership with Anthropic's AI platform has generated positive sentiment, as reflected in the recent stock surge. The company's financials for Q3 2026 show revenue growth of 8.42% YoY and net income growth of 34.13% YoY.
Analysts have downgraded the stock due to concerns about AI disruption in the software sector. Insider and hedge fund selling have significantly increased, indicating a lack of confidence from key stakeholders. The broader software sector is under pressure, as evidenced by the iShares Expanded Tech-Software ETF's decline.
In Q3 2026, DocuSign reported revenue of $818.35M (up 8.42% YoY), net income of $83.73M (up 34.13% YoY), and EPS of $0.40 (up 33.33% YoY). However, gross margin slightly declined to 79.16% (-0.13% YoY).
Recent analyst activity includes downgrades and reduced price targets. Jefferies downgraded the stock to Hold with a price target of $45, citing ongoing risks and limited growth visibility. BTIG and HSBC also lowered price targets, reflecting concerns about AI disruption and lower growth prospects.
